SEARCH

SEARCH BY CITATION

References

  • Allen B & Baker FJ (1968) Mycobacteria: Isolation, identification and sensitivity testing. Butterworth, London.
  • Canetti G, Fox W, Khomenko A et al. (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bulletin of the World Health Organization 41, 2143.
  • Cao JP, Zhanj LY, Zhu JQ & Chin DP (1998) Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China. International Journal of Tuberculosis and Lung Disease 2, 360364.
  • Ellard GA & Haslam RM (1976) Observations on the reduction of renal elimination of urate in man caused by administration of pyrazinamide. Tubercle 57, 97103.
  • Guy A, Dickinson JM & Mitchison DA (1993) Turning intermittent regimens into daily regimens using blister packs. An exploration in murine tuberculosis. Tubercle and Lung Diseases 74, 310316.
  • Hong Kong Chest Service/British Medical Research Council (HKCS/BMRC) (1982) Controlled clinical trial of 4 three-times weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report; The results up to 24 months. Tubercle 63, 8998.
  • Hong Kong Chest Service/British Medical Research Council (HKCS/BMRC) (1991) Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month, 3 times weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of Isoniazid, rifampicin and pyrazinamide. American Review of Respiratory Disease 143, 700706.
  • Kannapiran M, Krishnamurthy PV, Raghupati Sarma G et al. (1985) Uric acid disposition during treatment with intermittent chemotherapy of pulmonary tuberculosis patients with regimens containing rifampicin and pyrazinamide. Indian Journal of Medical Research 82, 116121.
  • Nazareth O, Acharyalu GS, Janardhanam B et al. (1984) Arthralgia in south Indian patients with pulmonary tuberculosis during treatment with pyrazinamide and rifampicin. Lung India 11, 231236.
  • Paramasivan CN, Herbert D & Prabhakar R (1993) Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid and pyrazinamide on Mycobacterium tuberculosis in vitro. Indian Journal of Medical Research (A) 97, 145150.
  • Paramasivan CN, Herbert D, Umapathy KC et al. (1994) Early bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid and pyrazinamide in pulmonary tuberculosis patients. Indian Journal of Medical Research 100, 14.
  • Parthasarathy R, Raghupati Sarma G, Janardhanam B et al. (1986) Hepatic toxicity in south Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle 67, 99108.
  • Prabhakar R (1986) Fully intermittent six-month regimens for pulmonary tuberculosis in south India. Professional postgraduate services Proceedings of the XXVI World Conference of the International Union Against Tuberculosis, Singapore, 4–7 November.
  • Raghupati Sarma G, Acharyalu GS, Kannapiran M et al. (1983) Role of rifampicin in arthralgia induced by pyrazinamide. Tubercle 64, 93100.
  • Rani B (1991) Fully intermittent six-month regimens for pulmonary tuberculosis in south India. Indian Journal of Tuberculosis 38, 5153.
  • Tuberculosis Research Centre, Madras (1983) Study of chemotherapy regimens of 5 and 7 months duration and the role of cortico-steroids in the treatment of sputum positive patients with pulmonary tuberculosis in south India. Tubercle 64, 7391.
  • Tuberculosis Research Centre, Madras (1997) A controlled clinical trial of oral short-course regimens in the treatment of sputum positive pulmonary tuberculosis. International Journal of Tuberculosis and Lung Diseases 1, 509517.